RIL
AMPH icon

Rothschild Investment LLC’s Amphastar Pharmaceuticals AMPH Stock Holding History

Rothschild Investment LLC’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.57K Buy
177
+176
+17,600% +$3.55K ﹤0.01% 2465
2026
Q1 		$20 Sell
1
-24
-96% -$587 ﹤0.01% 3534
2025
Q4 		$670 Buy
25
+10
+67% +$258 ﹤0.01% 2831
2025
Q3 		$400 Sell
15
-80
-84% -$2.07K ﹤0.01% 2880
2025
Q2 		$2.18K Buy
95
+35
+58% +$869 ﹤0.01% 2022
2025
Q1 		$1.74K Buy
60
+50
+500% +$1.6K ﹤0.01% 1981
2024
Q4 		$371 Sell
10
-25
-71% -$1.14K ﹤0.01% 2642
2024
Q3 		$1.7K Buy
35
+20
+133% +$878 ﹤0.01% 1811
2024
Q2 		$600 Buy
15
+10
+200% +$414 ﹤0.01% 1901
2024
Q1 		$220 Buy
+5
New +$258 ﹤0.01% 1708

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
LG
LAM Group Lake Oswego, Oregon $201M AUM 22.35% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Rothschild Investment LLC's AMPH Position: Q2 2026 in Review

Rothschild Investment LLC increased its Amphastar Pharmaceuticals (AMPH) stake by 17,600% in Q2 2026, buying an estimated $3.55K and bringing the position to 177 shares worth $3.57K. The position accounts for ﹤0.01% of the portfolio, ranked #2465.

Rothschild Investment LLC first reported a position in AMPH in Q1 2024 and has held it in 10 quarters since. 82 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Rothschild Investment LLC held 177 shares of Amphastar Pharmaceuticals worth $3.57K as of Q2 2026.
  • Rothschild Investment LLC bought 176 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $3.55K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2465 holding.
  • Rothschild Investment LLC first reported a position in Amphastar Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • 82 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.